Improving Metabolic Monitoring for Children Prescribed Second-Generation Antipsychotics

The number of children taking second-generation antipsychotics (SGA) is increasing. While SGAs produce fewer neurological side effects, the metabolic side effects of SGAs increase the risk for future cardiometabolic disease. In 2011, the American Academy of Child and Adolescent Psychiatry endorsed following guidelines established in 2004 recommending that people taking SGAs receive regular metabolic screening including waist circumference measurement, fasting blood glucose, and fasting lipids. Despite recommendations, studies have shown that children do not receive routine metabolic monitoring. Provider attitudes toward following guidelines can influence the rates of monitoring.

Research suggests that monitoring rates improve after psychiatric providers receive educational programs on SGA use and recommended guidelines. In response to these findings, an evidence-based educational intervention discussing SGA use in children and recommended metabolic monitoring was proposed to increase the rates of metabolic monitoring in a community-based psychiatric practice that treats children. While no results were statistically significant, the average attitude score of providers toward following guidelines was higher post-education and the proportion of providers who ordered screening tests post-education increased. To further improve metabolic monitoring, it is recommended that interventions designed to increase the subjective norms and perceived behavioral control of providers be implemented. The main limitations of this project were the small sample size and the use of self-reports to assess provider ordering of screening tests.